Skip to main content

Table 2 Cytokine levels in each patient group

From: An increase in mean platelet volume after admission is associated with higher mortality in critically ill patients

Cytokine (pg/mL), median (IQ)

ΔPlat24h ≤ 0

ΔPlat24h ≥ 0

 

ΔMPV24h ≤ 0

ΔMPV24h ≥ 0

ΔMPV24h ≤ 0

ΔMPV24h ≥ 0

P-value

IL1β

2.14 (1.49;3.91)

2.07 (1.49;4.23)

1.84 (0.95;5.45)

2.13 (1.22;3.19)

0.793

IL6

37.33 (10.44;80.23)

57.43 (17.64;404.0)

25.98 (10.77;55.93)

40.08 (10.34;96.83)

0.187

IL8

32.00 (19.52;58.75)

57.14 (22.34;134.20)

24.42 (8.71;65.96)

40.13 (30.18;54.41)

0.174

IL10

19.4 (6.89;44.03)

38.41 (9.41;79.47)

12.68 (4.21;25.76)

9.15 (6.21;14.02)

0.163

TNFα

26.79 (11.72;45.42)

22.62 (15.81;46.91)

26.94 (12.11;33.99)

19.17 (11.64;28.8)

0.753

IFNα

69.0 (39.17;95.2)

62.96 (52.56;82.56)

71.14 (53.01;104.3)

69.01 (53.15;75.26)

0.742

EGF

158.5 (127.20;341.8)

165.0 (127.8;247.8)

245.5 (115.2;272.2)

188 (150.5;350)

0.932

VEGF

188 (114;427.8)

153 (111;274.2)

128 (80.45;293.8)

161 (132;390)

0.784

  1. No post hoc analysis was performed. EGF, epidermal growth factor; VEGF, vascular endothelial growth factor.
  2. P-value for Kruskal-Wallis test.